Rmb Capital Management Lowers stake in Cooper Companies Inc (COO)

Cooper Companies Inc (COO) : Rmb Capital Management reduced its stake in Cooper Companies Inc by 1.81% during the most recent quarter end. The investment management company now holds a total of 169,134 shares of Cooper Companies Inc which is valued at $26,379,830 after selling 3,109 shares in Cooper Companies Inc , the firm said in a disclosure report filed with the SEC on May 9, 2016.Cooper Companies Inc makes up approximately 1.95% of Rmb Capital Management’s portfolio.

Other Hedge Funds, Including , Ibm Retirement Fund reduced its stake in COO by selling 6,896 shares or 58.7% in the most recent quarter. The Hedge Fund company now holds 4,851 shares of COO which is valued at $756,610. Cooper Companies Inc makes up approx 0.03% of Ibm Retirement Fund’s portfolio.American Century Companies Inc reduced its stake in COO by selling 120,437 shares or 15.48% in the most recent quarter. The Hedge Fund company now holds 657,789 shares of COO which is valued at $100,845,632. Cooper Companies Inc makes up approx 0.12% of American Century Companies Inc’s portfolio.First Mercantile Trust Co reduced its stake in COO by selling 292 shares or 6.15% in the most recent quarter. The Hedge Fund company now holds 4,459 shares of COO which is valued at $682,584. Cooper Companies Inc makes up approx 0.08% of First Mercantile Trust Co’s portfolio.Quantbot Technologies Lp boosted its stake in COO in the latest quarter, The investment management firm added 144 additional shares and now holds a total of 3,577 shares of Cooper Companies Inc which is valued at $547,567. Cooper Companies Inc makes up approx 0.09% of Quantbot Technologies Lp’s portfolio.

Cooper Companies Inc opened for trading at $155.69 and hit $157.9 on the upside on Friday, eventually ending the session at $155.97, with a gain of 0.36% or 0.56 points. The heightened volatility saw the trading volume jump to 2,40,465 shares. Company has a market cap of $7,548 M.

On the company’s financial health, Cooper Companies Inc reported $1.83 EPS for the quarter, beating the analyst consensus estimate by $ 0.25 according to the earnings call on Mar 3, 2016. Analyst had a consensus of $1.58. The company had revenue of $449.60 million for the quarter, compared to analysts expectations of $442.03 million. The company’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.75 EPS.

Many Wall Street Analysts have commented on Cooper Companies Inc. Cooper Companies Inc was Upgraded by Jefferies to ” Buy” on Apr 15, 2016.

The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch SeeClear and Mobius.

Leave a Reply

Cooper Companies Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cooper Companies Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.